Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Lichen planus commonly affects middle-aged adults, often involves limbs and mucosal areas, and can be linked to immune diseases.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The study found increased skin pigmentation and variable melanocyte density in a patient with Addison's disease.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Different diseases cause specific skin and hair follicle changes in dogs with alopecia.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.